The nuclear factor-kappa B (NF-B) family of transcription factors plays a seminal role in inflammation, apoptosis, development, and cancer. Modulation of NF-Bmediated gene expression in response to diverse signals is coordinated by the IB kinase (IKK) complex. We identified ELKS, an essential regulatory subunit of the IKK complex. Silencing ELKS expression by RNA interference blocked induced expression of NF-B target genes, including the NF-B inhibitor IB␣ and proinflammatory genes such as cyclo-oxygenase 2 and interleukin 8. These cells were also not protected from apoptosis in response to cytokines. ELKS likely functions by recruiting IB␣ to the IKK complex and thus serves a regulatory function for IKK activation.
plicated in chaperoning the IKK complex to the activated TNF receptor (14) .
We identified by gel filtration analysis and tandem mass spectrometry a 105-kD protein, ELKS, that copurified with an IKK complex that was immunoprecipitated with IKK2 antibodies from a human cell line (HeLa) treated with TNF-␣ (12, 15) [The name ELKS is derived from the relative abundance of its constitutive amino acids: glutamic acid (E), leucine (L), lysine (K), and serine (S) (16) ]. ELKS has previously been identified as a ubiquitous protein of unknown function (16, 17) . Secondary structure prediction of the ELKS sequence indicates coiled-coil motifs throughout the protein and a leucine zipper at the C terminus (fig. S1A). The IKK complex with the high molecular weight of 700 to 900 kD was also present in anti-ELKS immunoprecipitates from HeLa cells treated with TNF-␣, as determined by gel filtration and immunoblot analysis (Fig. 1A) .
Immunoprecipitation of ELKS from lysates of HeLa cells either treated with TNF-␣ or untreated contained endogenous IKK1, IKK2, and NEMO (Fig. 1B) . Additionally, antibodies to either IKK1, IKK2, or NEMO immunoprecipitated ELKS from lysates of cells that were treated with TNF-␣ or untreated (Fig. 1C) . Association of ELKS with the IKK complex was also identified in multiple cell types, including human embryonic kidney cells (293T) and human T-lymphocyte cells (Jurkat) (fig. S1B). Inducible IKK activity was also detected in ELKS that was immunoprecipitated from lysates of HeLa cells treated with TNF-␣ (Fig. 1D) . Similar results were obtained when epitope (Myc)-tagged ELKS (ELKS-Myc) was transiently expressed in transfected 293T cells ( fig. S1C ).
Increasing amounts of ELKS protein were immunoprecipitated when increasing amounts of ELKS antibody were used (Fig. 1E, top) , indicating that ELKS was progressively depleted from lysates of HeLa cells that were untreated or treated with TNF-␣ (Fig. 1E, bottom) .
Endogenous IKK1, IKK2, and NEMO were also depleted concomitantly regardless of TNF-␣ treatment (Fig. 1E, bottom) , suggesting that ELKS, IKK1, IKK2, and NEMO are stoichiometric integral components of the functional high-molecular weight IKK complex.
To determine whether ELKS specifically associates with each of the three wellcharacterized components of the IKK complex, ELKS-Myc was transiently expressed with either epitope-tagged IKK1 [hemagglutinin (HA)], IKK2 (Flag), or NEMO [Glu-Glu (EE)] in 293T cells. Each component immunoprecipitated with ELKS-Myc from cell lysates (Fig. 1,  F to H) . The multiple ELKS bands observed may be alternatively processed forms or degradation products of transiently expressed ELKSMyc. ELKS and NEMO also coimmunoprecipitated from IKK1 Ϫ/Ϫ IKK2 Ϫ/Ϫ double knockout mouse embryonic fibroblast (MEF) cells, indicating that the association of ELKS and NEMO is independent of IKK1 and IKK2 (Fig. 1I ). Both immunofluorescence and biochemical fractionation revealed that ELKS is localized in the cytoplasm where the IKK complex resides (fig. S1, D and E).
To address whether ELKS is essential for IKK activity and NF-B activation, ELKS expression was reduced by RNA interference. A lentiviral vector was generated to synthesize ELKS small interfering RNA (LV-siELKS) by the human H1 polymerase III promoter (18) (19) (20) (Fig. 2A) . Five days after infection, lysates from HeLa cells transduced with either LVsiELKS or a control lentiviral vector that synthesized siRNA against green fluorescent protein (LV-siGFP) were immunoprecipitated with the antibody to ELKS, followed by immunoblot analysis. Several spliced variant isoforms of ELKS were generated that encode proteins ranging from 948 to 1116 amino acids (21) . The N-terminal ELKS antibody was generated against a peptide common to all isoforms. LVsiELKS reduced the expression of two major ELKS isoforms in HeLa cells as compared with expression in control cells. Expression of IKK1, IKK2, NEMO, and NF-B (composed of p65 and p50) remained stable in the absence of ELKS ( Fig. 2A) . ELKS silencing caused a loss and delay of IB␣ phosphorylation and degradation in response to TNF-␣ and IL-1, whereas IB␣ from control cells displayed a normal profile of phosphorylation, degradation, and resynthesis in response to cytokines (Fig. 2B) . Lysates from LV-siGFP or LV-siELKS transduced HeLa cells that were treated with TNF-␣ were immunoprecipitated with an antibody to NEMO and were assessed for IKK activity. In the absence of ELKS, IKK displayed reduced ability to phosphorylate an exogenous substrate glutathione S-transferase (GST)-IB␣, residues 1 to 54 [GST-IB␣(1-54)] (a fusion protein of GST and IB␣) (Fig. 2C) .
Failure to activate IKK activity and degrade IB␣ resulted in the loss of DNA binding ac- tivity of NF-B to a radiolabeled consensus B-oligonucleotide probe in response to TNF-␣ or IL-1 (Fig. 3A) . In contrast, binding of an unrelated transcription factor, Oct-1, to its cognate DNA binding site was not impaired in these same extracts (Fig. 3A) .
We also measured the effect of ELKS on the induction of the NF-B targets IB␣, cyclooxygenase 2 (COX2), and interleukin 8 (IL-8), genes important in facilitating an immune response and inflammation (22) . Normal levels of induced gene expression were observed in LVsiGFP cells treated with TNF-␣ as determined by real-time polymerase chain reaction (PCR). In contrast, gene expression was diminished in cells transduced with LV-siELKS (Fig. 3B) . Expression levels of NF-B independent genes, IB␤ and BRCA1, were unaffected in the absence of ELKS regardless of TNF-␣ treatment, indicating that the loss of gene expression was specific to NF-B. In addition, luciferase reporter activity under the control of a human immunodeficiency virus (HIV)-NF-B promoter was repressed, 4 hours post-cytokine induction in LV-siELKS cells (Fig. 3C) . Another siRNA specifically targeting ELKS also diminished luciferase reporter activity in HeLa cells (base pairs 102 to 105 5ЈAACCAACAG-TACGGGAGGGAG3Ј), suggesting that siELKS effects are due to loss of target gene product and not due to indiscriminate nontarget gene effects.
The physiological role of NF-B's ability to protect cells from apoptosis was also examined in cells lacking ELKS. HeLa cells are normally resistant to apoptosis induced by TNF-␣; however, suppression of NF-B activity can sensitize cells to apoptosis (23) (24) (25) . HeLa cells transduced with LV-siELKS displayed an increased sensitivity to apoptosis induced by TNF-␣. Blebbing nuclei (Fig. 3D) , poly(adenosine 5Ј-diphosphate-ribose) polymerase (PARP) cleavage, and pro-Caspase3 cleavage (Fig. 3E) , indicative of apoptosis, were increased in HeLa cells transduced with LV-siELKS, compared with cells transduced with LV-siGFP. Thus, in cells lacking ELKS, the failure to activate NF-B results in a lack of the survival gene expression necessary to protect the cells from apoptosis induced by TNF-␣.
Previous studies have shown that the IKK complex associates with a small amount of IB␣ at basal levels, and upon cytokine induction, IB␣ is actively recruited to the highmolecular weight IKK complex as a target for phosphorylation (26, 27) . Consistent with these studies, IB␣ was found in association with the IKK complex in HeLa cells treated with TNF-␣ or untreated (Fig. 4A and fig. S2 ). NEMO has been implicated in facilitating IB␣ recruitment to the IKK complex upon IKK activation, although NEMO and IB␣ do not directly interact unless IKK2 is present (26) . Coimmunoprecipitation of epitope-tagged IB␣ (Myc) and ELKS (V5) indicated that a specific interaction between ELKS and IB␣ exists (Fig. 4B) . Additionally, increasing amounts of IB␣ were associated with increasing amounts of ELKS, but there was no concomitant increase of IKK activity (Fig. 4C) , suggesting that ELKS association with IB␣ is independent of IKK activity. This suggests that ELKS may directly recruit IB␣ to the IKK complex. Consistent with this model, a reduction of ELKS protein levels in the cell not only diminished IKK activity but also delayed phosphorylation of IB␣ (Fig. 2B) .
We further identified an N-terminal deletion mutant (amino acids 1 to 134 deleted) of ELKS [ELKS(⌬N)] that facilitated the recruitment of IB␣ and the induction of IKK and NF-B activity in the absence of cytokine stimulation. Increased expression levels of ELKS(⌬N) resulted in enhanced NF-B-dependent luciferase reporter gene activity in the absence of inducing stimuli, as compared with wild-type ELKS (Fig. 4E) . As a control, another luciferase reporter under the control of the thymidine kinase promoter was unaffected (28) . In contrast to wild-type ELKS, increased ELKS(⌬N) expression was associated with a decrease in endogenous IB␣ interaction (Fig.  4D) . Immunoblot analysis of cell lysates also revealed decreased levels of IB␣ in these cells. In the absence of cytokine stimulation, kinase assays of ELKS(⌬N) immunoprecipitates revealed increased IKK activity with increasing amounts of ELKS(⌬N) (Fig. 4D) leading to the degradation of IB␣. This would account for decreased IB␣ protein levels and enhanced NF-B activity.
We propose that ELKS mediates an essential step in IKK activation. ELKS(⌬N) may exist in a conformational state that enhances IKK activity and IB␣ recruitment in the absence of upstream stimulation. ELKS was initially identified from a papillary thyroid carcinoma as part of a translocation fusion protein with the receptor tyrosine kinase (RET), also known as tyrosine receptor kinase A (TRKA), tyrosine kinase domain (ELKS-RET) (16, 17) . Oligomerization of ELKS-RET chimeric proteins through the coiled-coil domain of ELKS dimerized the RET kinase domains. This resulted in the constitutive autophosphorylation of the RET tyrosine kinase, leading to the transforming function of ELKS-RET oncoproteins (16, 21) . Coordinated cascades of oligomerization events have been proposed as a mechanism of IKK activation (29) (30) (31) . Considering the context in which ELKS was initially identified, ELKS may contribute an important oligomerization interface to members of the IKK complex as well as to other upstream or downstream regulators of NF-B transcriptional activity, such as IB␣. -fold rate enhancements over the uncatalyzed reaction, and are biologically active, in that they support the growth of Escherichia coli under gluconeogenic conditions. The inherent generality of the design method suggests that many enzymes can be designed by this approach.
Enzymes are among the most proficient catalysts known (1), and they catalyze a wide variety of reactions in aqueous solutions under ambient conditions with exquisite selectivity and stereospecificity (2, 3) . The rational design of enzymes has tremendous practical potential for developing novel synthetic biochemical pathways (4, 5) , but presents a formidable challenge and is one of the most stringent tests for understanding protein chemistry. Here, we present structure-based computational design techniques (6, 7) that predict mutations for the construction of catalytically active sites in proteins of known structure. Using these methods, we converted ribose-binding protein (8) into analogs (NovoTims) of the glycolytic enzyme triose phosphate isomerase (9) . Several NovoTims exhibit rate enhancements of about 10 5 to 10 6 and are biologically active, as seen in their support of the growth of Escherichia coli under gluconeogenic conditions. Triose phosphate isomerase (TIM) is an essential component of the Embden-Meyerhof pathway (10), interconverting dihydroxyacetone phosphate (DHAP) and glyceraldehyde 3-phosphate (GAP) (Fig. 1A) . In glycolysis, TIM channels these two triose phosphate products of aldolase into pyruvate; in gluconeogenesis, 
